Abstract
Diabetes insipidus is known to be associated with neurodevelopmental disorders. In this case report, we present a child suffering from a central diabetes insipidus (DI) and an attention-deficit/hyperactivity disorder (ADHD). The DI was due to a mutation on the vasopressin gene, impairing its secretion. We discuss the effects of this impairment on the central nervous system and how it might be linked to ADHD symptoms.
Similar content being viewed by others
References
American Psychiatric Association, American Psychiatric Association (ed) (2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. American Psychiatric Association, Washington, DC
Bilgiç A, Toker A, Uysal S (2016) Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci 70:442–447. https://doi.org/10.1111/pcn.12415
Blum K, Chen AL-C, Braverman ER et al (2008) Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 4:893–918
Born J, Pietrowsky R, Fehm HL (1998) Neuropsychological effects of vasopressin in healthy humans. Prog Brain Res 119:619–643
Brook CGD, Clayton PE, Brown RS, Wiley InterScience (Online service) (2009) Brook’s clinical pediatric endocrinology. Wiley-Blackwell, Hoboken
Bruins J, Kovács GL, Abbes AP et al (2006) Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus. Psychoneuroendocrinology 31:80–91. https://doi.org/10.1016/j.psyneuen.2005.06.001
de Wied D, Diamant M, Fodor M (1993) Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 14:251–302. https://doi.org/10.1006/frne.1993.1009
DuPaul GJ (ed) (1998) ADHD rating scale-IV: checklists, norms, and clinical interpretation. Guilford Press, New York
Ebstein RP, Knafo A, Mankuta D et al (2012) The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav 61:359–379. https://doi.org/10.1016/j.yhbeh.2011.12.014
Egashira N, Tanoue A, Higashihara F et al (2004) V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. Neurosci Lett 356:195–198. https://doi.org/10.1016/j.neulet.2003.11.050
Engelmann M, Landgraf R (1994) Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats. Physiol Behav 55:145–149
Faraone SV, Perlis RH, Doyle AE et al (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323. https://doi.org/10.1016/j.biopsych.2004.11.024
Frank E, Landgraf R (2008) The vasopressin system—from antidiuresis to psychopathology. Eur J Pharmacol 583:226–242. https://doi.org/10.1016/j.ejphar.2007.11.063
Hammock EAD, Young LJ (2006) Oxytocin, vasopressin and pair bonding: implications for autism. Philos Trans R Soc Lond B Biol Sci 361:2187–2198. https://doi.org/10.1098/rstb.2006.1939
Hebben N, Milberg W (2009) Essentials of neuropsychological assessment. Wiley, New York
Hoekstra JA, van Lieburg AF, Monnens LA et al (1996) Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 61:81–88. https://doi.org/10.1002/(SICI)1096-8628(19960102)61:1%3c81:AID-AJMG17%3e3.0.CO;2-S
Johnson ZV, Young LJ (2017) Oxytocin and vasopressin neural networks: implications for social behavioral diversity and translational neuroscience. Neurosci Biobehav Rev 76:87–98. https://doi.org/10.1016/j.neubiorev.2017.01.034
Kaplan RM, Saccuzzo DP (2013) Psychological testing: principles, applications, & issues, 8th edn. Wadsworth, Cengage Learning, Belmont
Klein RG, Mannuzza S, Olazagasti MAR et al (2012) Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69:1295. https://doi.org/10.1001/archgenpsychiatry.2012.271
Laczi F, László FA, Kovács GL et al (1987) Differential effect of desglycinamide9-(Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients. Acta Endocrinol (Copenh) 115:392–398
Langley K, Fowler T, Ford T et al (2010) Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 196:235–240. https://doi.org/10.1192/bjp.bp.109.066274
Loe IM, Feldman HM (2007) Academic and educational outcomes of children with ADHD. Ambul Pediatr Off J Ambul Pediatr Assoc 7:82–90. https://doi.org/10.1016/j.ambp.2006.05.005
Madras BK, Miller GM, Fischman AJ (2005) The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1397–1409. https://doi.org/10.1016/j.biopsych.2004.10.011
Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524–538. https://doi.org/10.1038/nrn3044
Mick E, Faraone SV (2008) Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17:261–284. https://doi.org/10.1016/j.chc.2007.11.011
Nabe K, Honjo S, Ikeda H et al (2007) Diabetes insipidus and cognitive function. Med Hypotheses 69:764–766. https://doi.org/10.1016/j.mehy.2007.01.081
Porter RS, Kaplan JL, Merck & Co (2011) The Merck manual of diagnosis and therapy. Merck Sharp & Dohme Corp., Whitehouse Station
Raggenbass M (2008) Overview of cellular electrophysiological actions of vasopressin. Eur J Pharmacol 583:243–254. https://doi.org/10.1016/j.ejphar.2007.11.074
Rittig S, Robertson GL, Siggaard C et al (1996) Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet 58:107–117
Skuse DH, Gallagher L (2011) Genetic influences on social cognition. Pediatr Res 69:85R–91R. https://doi.org/10.1203/PDR.0b013e318212f562
Swanson JM, Sunohara GA, Kennedy JL et al (1998) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38–41. https://doi.org/10.1038/sj.mp.4000354
Thapar A, Cooper M (2015) Attention deficit hyperactivity disorder. Lancet. https://doi.org/10.1016/S0140-6736(15)00238-X
Van West D, Del-Favero J, Deboutte D et al (2009) Arginine vasopressin receptor gene-based single-nucleotide polymorphism analysis in attention deficit hyperactivity disorder. Psychiatr Genet 19:102–103. https://doi.org/10.1097/YPG.0b013e32832a0b2b
Volkow ND, Wang G-J, Kollins SH et al (2009) Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302:1084–1091. https://doi.org/10.1001/jama.2009.1308
World Health Organization (ed) (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Irene Dupong, Dr Guilmin-Crepon, and Dr Peyre declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Informed consent
All of the included subjects gave their written informed consent for this publication.
Rights and permissions
About this article
Cite this article
Dupong, I., Guilmin-Crepon, S. & Hugo, P. ADHD symptoms in a young patient with central diabetes insipidus. ADHD Atten Def Hyp Disord 10, 317–320 (2018). https://doi.org/10.1007/s12402-018-0264-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12402-018-0264-y